The Initial Evaluation of Adults with Bronchiectasis

Clinics in Chest Medicine

Volumn 33, Issue 2, 2012, Pages 219-231

  Metersky, Mark L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiectasis; Diagnosis; Genetics; Immunodeficiency; Microbiology; Radiology

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; BRONCHIECTASIS; BRONCHOSCOPY; CLINICAL EVALUATION; DISEASE ASSOCIATION; GENETIC DISORDER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE DISPLAY; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; LUNG FUNCTION TEST; MEDICAL HISTORY; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST;

ADULT; BRONCHIECTASIS; COHORT STUDIES; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861534105     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2012.03.004     Document Type: Review

References (55)

1. O'Donnell A.E. Bronchiectasis. Chest 2008, 134(4):815-823.
2. Barker A.F. Bronchiectasis. N Engl J Med 2002, 346(18):1383-1393.
3. Feldman C. Bronchiectasis: new approaches to diagnosis and management. Clin Chest Med 2011, 32(3):535-546.
4. Wilson R. Bronchiectasis. Respiratory infections 2001, 347-359. Lippincott, Williams and Wilkins, Philadelphia. 2nd edition. M. Niederman (Ed.).
5. Pasteur M.C., Bilton D., Hill A.T. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010, 65(Suppl 1):i1-i58.
6. Vendrell M., de Gracia J., Olveira C., et al. Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery. Arch Bronconeumol 2008, 44(11):629-640.
7. Quast T.M., Self A.R., Browning R.F. Diagnostic evaluation of bronchiectasis. Dis Mon 2008, 54(8):527-539.
8. King P.T., Holdsworth S.R., Freezer N.J., et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006, 100(12):2183-2189.
9. Nicotra M.B., Rivera M., Dale A.M., et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995, 108(4):955-961.
10. Pasteur M.C., Helliwell S.M., Houghton S.J., et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000, 162(4 Pt 1):1277-1284.
11. Shoemark A., Ozerovitch L., Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007, 101(6):1163-1170.
12. O'Donnell A., Prevots D., Olivier K., et al. The bronchiectasis research registry: clinical, microbiologic, and treatment characteristics. Eur Respir J 2010, 36:A4034.
13. Couderc L.J., Catherinot E., Rivaud E., et al. Are investigations for underlying causes needed for the management of an adult patient with bronchiectasis?. Rev Pneumol Clin 2011, 67(4):267-274.
14. Reich J.M., Johnson R.E. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992, 101(6):1605-1609.
15. Kim R.D., Greenberg D.E., Ehrmantraut M.E., et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008, 178(10):1066-1074.
16. Goeminne P., Dupont L. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad Med J 2010, 86(1018):493-501.
17. Montella S., Santamaria F., Salvatore M., et al. Assessment of chest high-field magnetic resonance imaging in children and young adults with noncystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with pulmonary function. Invest Radiol 2009, 44(9):532-538.
18. Bhalla M., Turcios N., Aponte V., et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991, 179(3):783-788.
19. Eshed I., Minski I., Katz R., et al. Bronchiectasis: correlation of high-resolution CT findings with health-related quality of life. Clin Radiol 2007, 62(2):152-159.
20. Noori F., Abduljawad S., Suffin D.M., et al. Mounier-Kuhn syndrome: a case report. Lung 2010, 188(4):353-354.
21. Lee P.H., Carr D.H., Rubens M.B., et al. Accuracy of CT in predicting the cause of bronchiectasis. Clin Radiol 1995, 50(12):839-841.
22. Cartier Y., Kavanagh P.V., Johkoh T., et al. Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases. AJR Am J Roentgenol 1999, 173(1):47-52.
23. Reiff D.B., Wells A.U., Carr D.H., et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol 1995, 165(2):261-267.
24. De Gracia J., Rodrigo M.J., Morell F., et al. IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med 1996, 153(2):650-655.
25. Martinez-Garcia M.A., Perpina-Tordera M., Roman-Sanchez P., et al. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir Med 2006, 100(9):1623-1632.
26. Stead A., Douglas J.G., Broadfoot C.J., et al. Humoral immunity and bronchiectasis. Clin Exp Immunol 2002, 130(2):325-330.
27. Hill S.L., Mitchell J.L., Burnett D., et al. IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax 1998, 53(6):463-468.
28. King P.T., Hutchinson P., Holmes P.W., et al. Assessing immune function in adult bronchiectasis. Clin Exp Immunol 2006, 144(3):440-446.
29. Parr D.G., Guest P.G., Reynolds J.H., et al. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2007, 176(12):1215-1221.
30. Nick J.A., Rodman D.M. Manifestations of cystic fibrosis diagnosed in adulthood. Curr Opin Pulm Med 2005, 11(6):513-518.
31. O'Donnell A.E., Barker A.F., Ilowite J.S., et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998, 113(5):1329-1334.
32. Bienvenu T., Sermet-Gaudelus I., Burgel P.R., et al. conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010, 181(10):1078-1084.
33. Marthin J.K., Nielsen K.G. Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia. Eur Respir J 2011, 37(3):559-565.
34. Corbelli R., Bringolf-Isler B., Amacher A., et al. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest 2004, 126(4):1054-1059.
35. Storm van's Gravesande K., Omran H. Primary ciliary dyskinesia: clinical presentation, diagnosis and genetics. Ann Med 2005, 37(6):439-449.
36. Cowan M.J., Gladwin M.T., Shelhamer J.H. Disorders of ciliary motility. Am J Med Sci 2001, 321(1):3-10.
37. Paulson M.L., Freeman A.F., Holland S.M. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol 2008, 8(6):527-533.
38. Vinh D.C., Sugui J.A., Hsu A.P., et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010, 125(6):1389-1390.
39. Thomson R.M., Armstrong J.G., Looke D.F. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease. Chest 2007, 131(4):1166-1172.
40. Koh W.J., Lee J.H., Kwon Y.S., et al. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest 2007, 131(6):1825-1830.
41. Wilson C.B., Jones P.W., O'Leary C.J., et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998, 12(4):820-824.
42. Murray M.P., Turnbull K., Macquarrie S., et al. Assessing response to treatment of exacerbations of bronchiectasis in adults. Eur Respir J 2009, 33(2):312-318.
43. Loebinger M.R., Shoemark A., Berry M., et al. Procalcitonin in stable and unstable patients with bronchiectasis. Chron Respir Dis 2008, 5(3):155-160.
44. Murray M.P., Turnbull K., MacQuarrie S., et al. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J 2009, 34(1):125-131.
45. Wilson C.B., Jones P.W., O'Leary C.J., et al. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997, 156(2 Pt 1):536-541.
46. Quittner A.L., Salathe M., Gotfried M., et al. National validation of a patient-reported outcome measure for bronchiectasis: psychometric results on the QOL-B. Am J Respir Crit Care Med 2010, 181:A5793.
47. Loebinger M.R., Wells A.U., Hansell D.M., et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009, 34(4):843-849.
48. van Haren E.H., Lammers J.W., Festen J., et al. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir Med 1995, 89(3):209-214.
49. Griffith D.E., Brown-Elliott B.A., Langsjoen B., et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006, 174(8):928-934.
50. Griffith D.E., Aksamit T., Brown-Elliott B.A., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175(4):367-416.
51. Ferrer A., Llorenc V., Codina G., et al. Nocardiosis and bronchiectasis. An uncommon association?. Enferm Infecc Microbiol Clin 2005, 23(2):62-66.
52. Tanaka E., Amitani R., Niimi A., et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997, 155(6):2041-2046.
53. Fajac I., Viel M., Sublemontier S., et al. Could a defective epithelial sodium channel lead to bronchiectasis. Respir Res 2008, 9:46.
54. Boucher R.C. Bronchiectasis: a continuum of ion transport dysfunction or multiple hits?. Am J Respir Crit Care Med 2010, 181(10):1017-1019.
55. Fevang B., Mollnes T.E., Holm A.M., et al. Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis. Clin Exp Immunol 2005, 142(3):576-584.